Skip to content
DataLookout
Menu

OSEMNCT07885033

Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Oral symptom burden: area under the weekly oral symptom score curve
Timeframe: From the first delivered radiation fraction (Time 0) through the end-of-treatment assessment, up to 7 weeks and the a 4 week end of trial follow up.

Secondary (8)

Peak oral symptom severity
Time to first moderate or worse oral symptom
Proportion of participants reaching severe or very severe oral symptom severity
Unplanned acute-care use attributable to oral toxicity
Unplanned radiation treatment interruption attributable to oral toxicity
Show 3 moreShow less
Enteral or parenteral nutrition escalation attributable to oral toxicity
Change in body weight
Oral symptom burden at the follow-up assessment

Arms and interventions

OSEM ProgramExperimental

Participants receive the Peace of Mouth Kit at enrollment, at approximately week 5, and at the final treatment visit in week 7 - three kits in total - together with a structured review by the Premier clinical coordinator each week, immediately after radiation treatment. The weekly review consists of a fixed set of safety-flag questions, review of the participant's weekly symptom band and red-flag status, and assessment of kit use. Where the band or a red-flag criterion indicates it, the coordinator escalates directly to the on-call Premier radiation oncologist, who determines clinical management. The study does not direct clinical management. Premier standard of care continues unchanged, including the weekly radiation oncologist assessment and the after-hours on-call service.

STANDARD OF CARENo intervention

Participants receive Premier standard of care without modification, including the weekly radiation oncologist assessment, the after-hours on-call service, and any supportive-care measure the treating team judges appropriate. Participants complete the same baseline and weekly symptom questionnaire as the intervention arm, for research purposes only. The resulting symptom band is computed and retained for analysis but is not reviewed for escalation, is not returned to anyone, and does not generate any contact. There is no kit, no clinical coordinator review and no safety-flag questions. Kit components and equivalent products remain commercially available, and nothing is withheld from participants in this arm.

Other: ORAL CARE PRODUCT KIT

Sites

1 site in 1 country

  • Premier Cancer CenterClearwater, Florida, United States